Liver Fibrosis: Causes and Methods of Assessment, A Review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Hepatic fibrogenesis is the final result of injury to the liver. Fibrosis could lead to hepatic dysfunction, important in the pathogenesis of other chronic problems. Therefore, understanding the mechanism, accurate diagnosis and staging of it in early stages accelerates the treatment and reduces the prevalence of chirrosis. Treatment strategies of liver problems and detction methods depend on the amount and progression of liver fibrosis and the rate of cirrhosis development. Traditionally the invasive method, liver biopsy, is reference standard to follow progression and stage of fibrosis. However, during the past decade, progressive development of novel non-invasive methodologies has challenged the invasive method. Non-invasive methods have been initially introduced for chronic hepatitis C with increasing use in other chronic liver diseases. The need for liver biopsy has nowadays decreased significantly as a result of these methodologies. Most of the new non-invasive methods depend on either ‘biological’ or ‘physical’ approaches. In this review, starting from the mechanism of fibrogenesis, the current knowledge about diagnosis, treatment strategies and different methods for its evaluation is discussed. This is followed by a conclusion on what is expected to be known in this field during the future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Hazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310284200 · Cited by 320
Zhao, W., Zhang, L., Yin, Z., Su, W., Ren, G., Zhou, C., You, J., Fan, J., & Wang, X. (2011) · International Journal of Cancer · doi:10.1002/ijc.25920 · Cited by 115 · cited 1×
“The presence of HSCs around tumors and its microenvironment has been reported in a number of researches and case studies [9-12].”
BackgroundFloreani, A., Cazzagon, N., Martines, D., Cavalletto, L., Baldo, V., & Chemello, L. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.06.011 · Cited by 68
Cited by
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Update in global trends and aetiology of hepatocellular carcinoma
Rawla, P., Sunkara, T., Muralidharan, P., & Raj, J. P. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.78941 · Cited by 332
Porcine liver anatomy applied to biomedicine
Eberlova, L., Maleckova, A., Mik, P., Tonar, Z., Jirik, M., Mirka, H., Palek, R., Leupen, S., & Liska, V. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2019.12.038 · Cited by 45
Ma, J., Li, Y., Chen, M., Wang, W., Zhao, Q., He, B., Zhang, M., & Jiang, Y. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09714-4 · Cited by 37
“It is generally accepted that liver fibrosis acts as a risk factor for liver cancer and activated hepatic stellate cells (HSCs) are responsible for the progressive course of liver cancer (Toosi 2015).”
Background
Metadata
- Authors
- Karimzadeh Toosi, A. E.
- Venue
- Romanian Journal Of Internal Medicine
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-12-01
- Volume
- 53
- Issue
- 4
- Pages
- 304-314
- ISSN
- 1220-4749 (ISSN-L)
- OpenAlex
- W2288451153
- Cited by
- 84
- References
- 4
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver Fibrosis: Causes and Methods of Assessment, A Review. https://app.cochat.ai/papers/10.1515/rjim-2015-0039
- The paper
- Karimzadeh Toosi, A. E. (2015). Liver Fibrosis: Causes and Methods of Assessment, A Review. Romanian Journal Of Internal Medicine. https://doi.org/10.1515/rjim-2015-0039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.